nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—ADRB1—dilated cardiomyopathy	0.582	1	CbGaD
Amiodarone—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0608	0.409	CbGbCtD
Amiodarone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0467	0.314	CbGbCtD
Amiodarone—ABCB1—Spironolactone—dilated cardiomyopathy	0.0411	0.277	CbGbCtD
Amiodarone—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0289	0.345	CbGeAlD
Amiodarone—KCNH2—endocardium—dilated cardiomyopathy	0.0149	0.178	CbGeAlD
Amiodarone—CYP2C9—cardial valve—dilated cardiomyopathy	0.0121	0.144	CbGeAlD
Amiodarone—Cinchocaine—SCN5A—dilated cardiomyopathy	0.00411	0.744	CrCbGaD
Amiodarone—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00373	0.0298	CcSEcCtD
Amiodarone—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00235	0.0188	CcSEcCtD
Amiodarone—THRA—heart—dilated cardiomyopathy	0.00225	0.0269	CbGeAlD
Amiodarone—THRB—heart—dilated cardiomyopathy	0.00225	0.0269	CbGeAlD
Amiodarone—CACNA2D2—heart—dilated cardiomyopathy	0.00223	0.0266	CbGeAlD
Amiodarone—Drug eruption—Furosemide—dilated cardiomyopathy	0.00203	0.0162	CcSEcCtD
Amiodarone—Eruption—Furosemide—dilated cardiomyopathy	0.00203	0.0162	CcSEcCtD
Amiodarone—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.002	0.016	CcSEcCtD
Amiodarone—CACNA2D2—cardiac atrium—dilated cardiomyopathy	0.00191	0.0228	CbGeAlD
Amiodarone—CACNA1H—heart—dilated cardiomyopathy	0.00181	0.0216	CbGeAlD
Amiodarone—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00181	0.0144	CcSEcCtD
Amiodarone—Blindness—Lisinopril—dilated cardiomyopathy	0.00169	0.0135	CcSEcCtD
Amiodarone—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00167	0.0134	CcSEcCtD
Amiodarone—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00164	0.0196	CbGeAlD
Amiodarone—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00161	0.0129	CcSEcCtD
Amiodarone—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.00157	0.0188	CbGeAlD
Amiodarone—Ataxia—Spironolactone—dilated cardiomyopathy	0.00157	0.0125	CcSEcCtD
Amiodarone—ADRB1—myocardium—dilated cardiomyopathy	0.00154	0.0184	CbGeAlD
Amiodarone—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0015	0.012	CcSEcCtD
Amiodarone—SIGMAR1—myocardium—dilated cardiomyopathy	0.00148	0.0177	CbGeAlD
Amiodarone—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00143	0.0114	CcSEcCtD
Amiodarone—Dronedarone—ADRB1—dilated cardiomyopathy	0.00141	0.256	CrCbGaD
Amiodarone—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00139	0.0111	CcSEcCtD
Amiodarone—Drug interaction—Furosemide—dilated cardiomyopathy	0.00135	0.0108	CcSEcCtD
Amiodarone—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00133	0.0106	CcSEcCtD
Amiodarone—Vasculitis—Furosemide—dilated cardiomyopathy	0.00128	0.0102	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00127	0.0102	CcSEcCtD
Amiodarone—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00127	0.0101	CcSEcCtD
Amiodarone—Renal failure—Spironolactone—dilated cardiomyopathy	0.00126	0.0101	CcSEcCtD
Amiodarone—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00125	0.0149	CbGeAlD
Amiodarone—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00122	0.00978	CcSEcCtD
Amiodarone—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00122	0.00978	CcSEcCtD
Amiodarone—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0012	0.00958	CcSEcCtD
Amiodarone—KCNH2—myocardium—dilated cardiomyopathy	0.00118	0.0141	CbGeAlD
Amiodarone—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00117	0.00938	CcSEcCtD
Amiodarone—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00109	0.00872	CcSEcCtD
Amiodarone—ADRB1—heart—dilated cardiomyopathy	0.00108	0.0128	CbGeAlD
Amiodarone—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00106	0.0126	CbGeAlD
Amiodarone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00105	0.00837	CcSEcCtD
Amiodarone—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00103	0.00826	CcSEcCtD
Amiodarone—SIGMAR1—heart—dilated cardiomyopathy	0.00103	0.0123	CbGeAlD
Amiodarone—Alopecia—Spironolactone—dilated cardiomyopathy	0.00102	0.00815	CcSEcCtD
Amiodarone—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00101	0.00808	CcSEcCtD
Amiodarone—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.001	0.00803	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000961	0.00768	CcSEcCtD
Amiodarone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00096	0.00768	CcSEcCtD
Amiodarone—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000937	0.00749	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000937	0.00749	CcSEcCtD
Amiodarone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000931	0.00744	CcSEcCtD
Amiodarone—ADRB1—cardiac atrium—dilated cardiomyopathy	0.00092	0.011	CbGeAlD
Amiodarone—Wheezing—Lisinopril—dilated cardiomyopathy	0.00091	0.00728	CcSEcCtD
Amiodarone—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00091	0.00728	CcSEcCtD
Amiodarone—Malaise—Spironolactone—dilated cardiomyopathy	0.000905	0.00724	CcSEcCtD
Amiodarone—SIGMAR1—cardiac atrium—dilated cardiomyopathy	0.000883	0.0105	CbGeAlD
Amiodarone—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00088	0.00703	CcSEcCtD
Amiodarone—Photophobia—Lisinopril—dilated cardiomyopathy	0.00088	0.00703	CcSEcCtD
Amiodarone—Discomfort—Spironolactone—dilated cardiomyopathy	0.000844	0.00675	CcSEcCtD
Amiodarone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000834	0.00667	CcSEcCtD
Amiodarone—Confusional state—Spironolactone—dilated cardiomyopathy	0.000826	0.0066	CcSEcCtD
Amiodarone—KCNH2—heart—dilated cardiomyopathy	0.000821	0.00981	CbGeAlD
Amiodarone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000819	0.00655	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000817	0.00653	CcSEcCtD
Amiodarone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000802	0.00641	CcSEcCtD
Amiodarone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0008	0.00639	CcSEcCtD
Amiodarone—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000786	0.00628	CcSEcCtD
Amiodarone—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000779	0.00622	CcSEcCtD
Amiodarone—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000776	0.0062	CcSEcCtD
Amiodarone—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000775	0.00619	CcSEcCtD
Amiodarone—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000768	0.00614	CcSEcCtD
Amiodarone—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000757	0.00605	CcSEcCtD
Amiodarone—Eczema—Lisinopril—dilated cardiomyopathy	0.000757	0.00605	CcSEcCtD
Amiodarone—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000754	0.00602	CcSEcCtD
Amiodarone—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000737	0.00589	CcSEcCtD
Amiodarone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000734	0.00587	CcSEcCtD
Amiodarone—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000718	0.00574	CcSEcCtD
Amiodarone—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000715	0.00572	CcSEcCtD
Amiodarone—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000715	0.00571	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000707	0.00565	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000703	0.00562	CcSEcCtD
Amiodarone—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000703	0.00839	CbGeAlD
Amiodarone—CYP1A1—heart—dilated cardiomyopathy	0.000694	0.00829	CbGeAlD
Amiodarone—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000693	0.00554	CcSEcCtD
Amiodarone—Renal failure—Furosemide—dilated cardiomyopathy	0.000687	0.00549	CcSEcCtD
Amiodarone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000675	0.0054	CcSEcCtD
Amiodarone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000675	0.0054	CcSEcCtD
Amiodarone—Sweating—Furosemide—dilated cardiomyopathy	0.00067	0.00536	CcSEcCtD
Amiodarone—CYP2C9—heart—dilated cardiomyopathy	0.000668	0.00797	CbGeAlD
Amiodarone—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000652	0.00521	CcSEcCtD
Amiodarone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000651	0.0052	CcSEcCtD
Amiodarone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000648	0.00518	CcSEcCtD
Amiodarone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000647	0.00517	CcSEcCtD
Amiodarone—Ataxia—Lisinopril—dilated cardiomyopathy	0.00064	0.00511	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000613	0.0049	CcSEcCtD
Amiodarone—Visual impairment—Furosemide—dilated cardiomyopathy	0.000605	0.00483	CcSEcCtD
Amiodarone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000604	0.00482	CcSEcCtD
Amiodarone—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000593	0.00709	CbGeAlD
Amiodarone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000593	0.00474	CcSEcCtD
Amiodarone—Tinnitus—Furosemide—dilated cardiomyopathy	0.000585	0.00468	CcSEcCtD
Amiodarone—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000582	0.00465	CcSEcCtD
Amiodarone—Pruritus—Spironolactone—dilated cardiomyopathy	0.00058	0.00463	CcSEcCtD
Amiodarone—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000578	0.00462	CcSEcCtD
Amiodarone—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000577	0.00461	CcSEcCtD
Amiodarone—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000573	0.00458	CcSEcCtD
Amiodarone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000561	0.00448	CcSEcCtD
Amiodarone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00056	0.00448	CcSEcCtD
Amiodarone—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000559	0.00446	CcSEcCtD
Amiodarone—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00055	0.0044	CcSEcCtD
Amiodarone—Erythema—Furosemide—dilated cardiomyopathy	0.000546	0.00437	CcSEcCtD
Amiodarone—THRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000544	0.0099	CbGpPWpGaD
Amiodarone—THRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000544	0.0099	CbGpPWpGaD
Amiodarone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000542	0.00433	CcSEcCtD
Amiodarone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000542	0.00433	CcSEcCtD
Amiodarone—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000537	0.00429	CcSEcCtD
Amiodarone—Weight increased—Lisinopril—dilated cardiomyopathy	0.000535	0.00428	CcSEcCtD
Amiodarone—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000535	0.00427	CcSEcCtD
Amiodarone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000532	0.00425	CcSEcCtD
Amiodarone—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000527	0.00422	CcSEcCtD
Amiodarone—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.000527	0.0096	CbGpPWpGaD
Amiodarone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000521	0.00416	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00052	0.00416	CcSEcCtD
Amiodarone—Rash—Spironolactone—dilated cardiomyopathy	0.000517	0.00413	CcSEcCtD
Amiodarone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000516	0.00413	CcSEcCtD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000516	0.00939	CbGpPWpGaD
Amiodarone—Renal failure—Lisinopril—dilated cardiomyopathy	0.000515	0.00412	CcSEcCtD
Amiodarone—Vision blurred—Furosemide—dilated cardiomyopathy	0.000515	0.00411	CcSEcCtD
Amiodarone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000514	0.00411	CcSEcCtD
Amiodarone—Headache—Spironolactone—dilated cardiomyopathy	0.000513	0.0041	CcSEcCtD
Amiodarone—Jaundice—Lisinopril—dilated cardiomyopathy	0.000511	0.00409	CcSEcCtD
Amiodarone—Sweating—Lisinopril—dilated cardiomyopathy	0.000503	0.00402	CcSEcCtD
Amiodarone—Agitation—Furosemide—dilated cardiomyopathy	0.000502	0.00401	CcSEcCtD
Amiodarone—Vertigo—Furosemide—dilated cardiomyopathy	0.000491	0.00392	CcSEcCtD
Amiodarone—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000489	0.00391	CcSEcCtD
Amiodarone—Nausea—Spironolactone—dilated cardiomyopathy	0.000487	0.00389	CcSEcCtD
Amiodarone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000479	0.00383	CcSEcCtD
Amiodarone—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000471	0.00376	CcSEcCtD
Amiodarone—Hallucination—Lisinopril—dilated cardiomyopathy	0.000468	0.00374	CcSEcCtD
Amiodarone—Dry mouth—Furosemide—dilated cardiomyopathy	0.000455	0.00363	CcSEcCtD
Amiodarone—Confusional state—Furosemide—dilated cardiomyopathy	0.000449	0.00359	CcSEcCtD
Amiodarone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000446	0.00356	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000446	0.00811	CbGpPWpGaD
Amiodarone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000445	0.00356	CcSEcCtD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.00044	0.00801	CbGpPWpGaD
Amiodarone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000439	0.00351	CcSEcCtD
Amiodarone—Shock—Furosemide—dilated cardiomyopathy	0.000439	0.00351	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000438	0.00798	CbGpPWpGaD
Amiodarone—Flushing—Lisinopril—dilated cardiomyopathy	0.000437	0.00349	CcSEcCtD
Amiodarone—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000437	0.00795	CbGpPWpGaD
Amiodarone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000436	0.00349	CcSEcCtD
Amiodarone—Skin disorder—Furosemide—dilated cardiomyopathy	0.000433	0.00346	CcSEcCtD
Amiodarone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000431	0.00344	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000427	0.00778	CbGpPWpGaD
Amiodarone—Anorexia—Furosemide—dilated cardiomyopathy	0.000425	0.0034	CcSEcCtD
Amiodarone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000421	0.00336	CcSEcCtD
Amiodarone—Hypotension—Furosemide—dilated cardiomyopathy	0.000417	0.00333	CcSEcCtD
Amiodarone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000416	0.00332	CcSEcCtD
Amiodarone—THRB—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000414	0.00753	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000414	0.00753	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000413	0.00751	CbGpPWpGaD
Amiodarone—Erythema—Lisinopril—dilated cardiomyopathy	0.00041	0.00328	CcSEcCtD
Amiodarone—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000401	0.00321	CcSEcCtD
Amiodarone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0004	0.0032	CcSEcCtD
Amiodarone—Back pain—Lisinopril—dilated cardiomyopathy	0.000396	0.00317	CcSEcCtD
Amiodarone—THRB—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000393	0.00715	CbGpPWpGaD
Amiodarone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000387	0.0031	CcSEcCtD
Amiodarone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000386	0.00309	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000385	0.00308	CcSEcCtD
Amiodarone—Fatigue—Furosemide—dilated cardiomyopathy	0.000384	0.00307	CcSEcCtD
Amiodarone—Tremor—Lisinopril—dilated cardiomyopathy	0.000384	0.00307	CcSEcCtD
Amiodarone—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000382	0.00695	CbGpPWpGaD
Amiodarone—Constipation—Furosemide—dilated cardiomyopathy	0.000381	0.00305	CcSEcCtD
Amiodarone—Pain—Furosemide—dilated cardiomyopathy	0.000381	0.00305	CcSEcCtD
Amiodarone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00038	0.00304	CcSEcCtD
Amiodarone—Angioedema—Lisinopril—dilated cardiomyopathy	0.000374	0.00299	CcSEcCtD
Amiodarone—Malaise—Lisinopril—dilated cardiomyopathy	0.00037	0.00295	CcSEcCtD
Amiodarone—Vertigo—Lisinopril—dilated cardiomyopathy	0.000368	0.00294	CcSEcCtD
Amiodarone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000367	0.00294	CcSEcCtD
Amiodarone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000364	0.00291	CcSEcCtD
Amiodarone—ABCB1—heart—dilated cardiomyopathy	0.00036	0.0043	CbGeAlD
Amiodarone—Cough—Lisinopril—dilated cardiomyopathy	0.000358	0.00286	CcSEcCtD
Amiodarone—Urticaria—Furosemide—dilated cardiomyopathy	0.000354	0.00283	CcSEcCtD
Amiodarone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000352	0.00282	CcSEcCtD
Amiodarone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000352	0.00282	CcSEcCtD
Amiodarone—Anxiety—Lisinopril—dilated cardiomyopathy	0.000348	0.00278	CcSEcCtD
Amiodarone—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000347	0.00632	CbGpPWpGaD
Amiodarone—Discomfort—Lisinopril—dilated cardiomyopathy	0.000345	0.00276	CcSEcCtD
Amiodarone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000341	0.00273	CcSEcCtD
Amiodarone—THRB—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000341	0.0062	CbGpPWpGaD
Amiodarone—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00034	0.00619	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00034	0.00619	CbGpPWpGaD
Amiodarone—Confusional state—Lisinopril—dilated cardiomyopathy	0.000337	0.0027	CcSEcCtD
Amiodarone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000334	0.00267	CcSEcCtD
Amiodarone—Oedema—Lisinopril—dilated cardiomyopathy	0.000334	0.00267	CcSEcCtD
Amiodarone—Infection—Lisinopril—dilated cardiomyopathy	0.000332	0.00266	CcSEcCtD
Amiodarone—Shock—Lisinopril—dilated cardiomyopathy	0.000329	0.00263	CcSEcCtD
Amiodarone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000328	0.00262	CcSEcCtD
Amiodarone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000327	0.00262	CcSEcCtD
Amiodarone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000326	0.00261	CcSEcCtD
Amiodarone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000325	0.0026	CcSEcCtD
Amiodarone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000323	0.00258	CcSEcCtD
Amiodarone—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000321	0.00584	CbGpPWpGaD
Amiodarone—Asthenia—Furosemide—dilated cardiomyopathy	0.00032	0.00256	CcSEcCtD
Amiodarone—Anorexia—Lisinopril—dilated cardiomyopathy	0.000319	0.00255	CcSEcCtD
Amiodarone—Pruritus—Furosemide—dilated cardiomyopathy	0.000315	0.00252	CcSEcCtD
Amiodarone—Hypotension—Lisinopril—dilated cardiomyopathy	0.000313	0.0025	CcSEcCtD
Amiodarone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000305	0.00244	CcSEcCtD
Amiodarone—Insomnia—Lisinopril—dilated cardiomyopathy	0.000302	0.00242	CcSEcCtD
Amiodarone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.0003	0.0024	CcSEcCtD
Amiodarone—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000298	0.00543	CbGpPWpGaD
Amiodarone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000298	0.00238	CcSEcCtD
Amiodarone—Dizziness—Furosemide—dilated cardiomyopathy	0.000295	0.00236	CcSEcCtD
Amiodarone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000294	0.00235	CcSEcCtD
Amiodarone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000291	0.00232	CcSEcCtD
Amiodarone—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00029	0.00528	CbGpPWpGaD
Amiodarone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000289	0.00231	CcSEcCtD
Amiodarone—Fatigue—Lisinopril—dilated cardiomyopathy	0.000288	0.0023	CcSEcCtD
Amiodarone—Constipation—Lisinopril—dilated cardiomyopathy	0.000286	0.00229	CcSEcCtD
Amiodarone—Pain—Lisinopril—dilated cardiomyopathy	0.000286	0.00229	CcSEcCtD
Amiodarone—Vomiting—Furosemide—dilated cardiomyopathy	0.000283	0.00227	CcSEcCtD
Amiodarone—CACNA1H—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000283	0.00516	CbGpPWpGaD
Amiodarone—Rash—Furosemide—dilated cardiomyopathy	0.000281	0.00225	CcSEcCtD
Amiodarone—Dermatitis—Furosemide—dilated cardiomyopathy	0.000281	0.00224	CcSEcCtD
Amiodarone—Headache—Furosemide—dilated cardiomyopathy	0.000279	0.00223	CcSEcCtD
Amiodarone—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000278	0.00506	CbGpPWpGaD
Amiodarone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000276	0.0022	CcSEcCtD
Amiodarone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000273	0.00219	CcSEcCtD
Amiodarone—Urticaria—Lisinopril—dilated cardiomyopathy	0.000266	0.00212	CcSEcCtD
Amiodarone—Nausea—Furosemide—dilated cardiomyopathy	0.000265	0.00212	CcSEcCtD
Amiodarone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000264	0.00211	CcSEcCtD
Amiodarone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000264	0.00211	CcSEcCtD
Amiodarone—THRB—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.00026	0.00473	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.00026	0.00473	CbGpPWpGaD
Amiodarone—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000256	0.00466	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000249	0.00453	CbGpPWpGaD
Amiodarone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000246	0.00197	CcSEcCtD
Amiodarone—EBP—Metabolism—ANKRD1—dilated cardiomyopathy	0.000244	0.00445	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—PSEN2—dilated cardiomyopathy	0.000244	0.00443	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00024	0.00438	CbGpPWpGaD
Amiodarone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00024	0.00192	CcSEcCtD
Amiodarone—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000239	0.00434	CbGpPWpGaD
Amiodarone—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	0.000238	0.00433	CbGpPWpGaD
Amiodarone—Pruritus—Lisinopril—dilated cardiomyopathy	0.000237	0.00189	CcSEcCtD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000234	0.00426	CbGpPWpGaD
Amiodarone—EBP—Metabolism—TAZ—dilated cardiomyopathy	0.00023	0.00418	CbGpPWpGaD
Amiodarone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000229	0.00183	CcSEcCtD
Amiodarone—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000227	0.00413	CbGpPWpGaD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000222	0.00405	CbGpPWpGaD
Amiodarone—Dizziness—Lisinopril—dilated cardiomyopathy	0.000221	0.00177	CcSEcCtD
Amiodarone—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000217	0.00395	CbGpPWpGaD
Amiodarone—Vomiting—Lisinopril—dilated cardiomyopathy	0.000213	0.0017	CcSEcCtD
Amiodarone—Rash—Lisinopril—dilated cardiomyopathy	0.000211	0.00169	CcSEcCtD
Amiodarone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000211	0.00168	CcSEcCtD
Amiodarone—Headache—Lisinopril—dilated cardiomyopathy	0.00021	0.00167	CcSEcCtD
Amiodarone—EBP—Metabolism—SDHA—dilated cardiomyopathy	0.000208	0.00378	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—NR3C2—dilated cardiomyopathy	0.000199	0.00363	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—NR3C2—dilated cardiomyopathy	0.000199	0.00363	CbGpPWpGaD
Amiodarone—Nausea—Lisinopril—dilated cardiomyopathy	0.000199	0.00159	CcSEcCtD
Amiodarone—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000197	0.00358	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000174	0.00317	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000174	0.00316	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000171	0.00311	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—TAZ—dilated cardiomyopathy	0.000164	0.00298	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000157	0.00286	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—ITGB1—dilated cardiomyopathy	0.000152	0.00277	CbGpPWpGaD
Amiodarone—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000151	0.00274	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000148	0.0027	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—SDHA—dilated cardiomyopathy	0.000148	0.00269	CbGpPWpGaD
Amiodarone—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000138	0.00251	CbGpPWpGaD
Amiodarone—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000132	0.00241	CbGpPWpGaD
Amiodarone—THRB—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00013	0.00236	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000127	0.00231	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000127	0.00231	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—NPPA—dilated cardiomyopathy	0.000125	0.00228	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—NPPA—dilated cardiomyopathy	0.000125	0.00228	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000124	0.00225	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000123	0.00225	CbGpPWpGaD
Amiodarone—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000123	0.00224	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—RAC1—dilated cardiomyopathy	0.000123	0.00223	CbGpPWpGaD
Amiodarone—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000116	0.00212	CbGpPWpGaD
Amiodarone—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000114	0.00208	CbGpPWpGaD
Amiodarone—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000112	0.00205	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000111	0.00202	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000109	0.00198	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000104	0.00189	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000101	0.00184	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.0001	0.00182	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	9.81e-05	0.00178	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—RAF1—dilated cardiomyopathy	9.72e-05	0.00177	CbGpPWpGaD
Amiodarone—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.61e-05	0.00175	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.39e-05	0.00171	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.33e-05	0.0017	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—CD36—dilated cardiomyopathy	9.28e-05	0.00169	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.77e-05	0.0016	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—RAC1—dilated cardiomyopathy	8.75e-05	0.00159	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	8.72e-05	0.00159	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.65e-05	0.00157	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.65e-05	0.00157	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.55e-05	0.00156	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—RAF1—dilated cardiomyopathy	8.13e-05	0.00148	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	8.11e-05	0.00148	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.04e-05	0.00146	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.04e-05	0.00146	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	7.82e-05	0.00142	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	7.81e-05	0.00142	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.77e-05	0.00141	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	7.65e-05	0.00139	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.63e-05	0.00139	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.37e-05	0.00134	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.18e-05	0.00131	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	7.03e-05	0.00128	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.96e-05	0.00127	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	6.88e-05	0.00125	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	6.72e-05	0.00122	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	6.72e-05	0.00122	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.65e-05	0.00121	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.59e-05	0.0012	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.59e-05	0.0012	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.54e-05	0.00119	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	6.4e-05	0.00117	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	6.4e-05	0.00117	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.31e-05	0.00115	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	6.25e-05	0.00114	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.13e-05	0.00111	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	6.08e-05	0.00111	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.95e-05	0.00108	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—RAF1—dilated cardiomyopathy	5.8e-05	0.00106	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	5.72e-05	0.00104	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.65e-05	0.00103	CbGpPWpGaD
Amiodarone—EBP—Metabolism—GPX1—dilated cardiomyopathy	5.65e-05	0.00103	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.59e-05	0.00102	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	5.58e-05	0.00101	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—EGFR—dilated cardiomyopathy	5.57e-05	0.00101	CbGpPWpGaD
Amiodarone—EBP—Metabolism—CD36—dilated cardiomyopathy	5.5e-05	0.001	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	5.43e-05	0.000988	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	5.27e-05	0.000959	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	5.24e-05	0.000954	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	5.17e-05	0.000941	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.07e-05	0.000922	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.05e-05	0.000918	CbGpPWpGaD
Amiodarone—EBP—Metabolism—AGT—dilated cardiomyopathy	4.95e-05	0.000901	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.91e-05	0.000893	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.91e-05	0.000893	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.81e-05	0.000875	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	4.74e-05	0.000863	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	4.74e-05	0.000863	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.68e-05	0.000852	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.56e-05	0.000831	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	4.4e-05	0.0008	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4.29e-05	0.00078	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	4.29e-05	0.00078	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	4.15e-05	0.000756	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	4.13e-05	0.000752	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	4.08e-05	0.000743	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.08e-05	0.000743	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GPX1—dilated cardiomyopathy	4.02e-05	0.000732	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4e-05	0.000728	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—EGFR—dilated cardiomyopathy	3.98e-05	0.000724	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—CD36—dilated cardiomyopathy	3.92e-05	0.000713	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	3.91e-05	0.000711	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.86e-05	0.000702	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	3.81e-05	0.000693	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TNF—dilated cardiomyopathy	3.79e-05	0.000689	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.78e-05	0.000688	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	3.74e-05	0.00068	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.72e-05	0.000678	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.72e-05	0.000678	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	3.58e-05	0.000652	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.57e-05	0.000649	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	3.53e-05	0.000643	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AGT—dilated cardiomyopathy	3.53e-05	0.000642	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.46e-05	0.00063	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.4e-05	0.000619	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.38e-05	0.000615	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.38e-05	0.000615	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.32e-05	0.000604	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.32e-05	0.000604	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	3.24e-05	0.000589	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	3.2e-05	0.000582	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.14e-05	0.000572	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.13e-05	0.000569	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.12e-05	0.000568	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	3.1e-05	0.000564	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.94e-05	0.000535	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.91e-05	0.00053	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.89e-05	0.000526	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.86e-05	0.000521	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.82e-05	0.000513	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.72e-05	0.000494	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.66e-05	0.000484	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.65e-05	0.000482	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.64e-05	0.00048	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.6e-05	0.000473	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.51e-05	0.000456	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	2.49e-05	0.000453	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.47e-05	0.000449	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	2.25e-05	0.00041	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.25e-05	0.000409	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.15e-05	0.000392	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.11e-05	0.000384	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.1e-05	0.000382	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.04e-05	0.000372	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.01e-05	0.000367	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2e-05	0.000363	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2e-05	0.000363	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.98e-05	0.000359	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.92e-05	0.00035	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.92e-05	0.00035	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.91e-05	0.000348	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.89e-05	0.000344	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.86e-05	0.000338	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.83e-05	0.000333	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.76e-05	0.000321	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.74e-05	0.000316	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.73e-05	0.000315	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.72e-05	0.000313	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.72e-05	0.000312	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.64e-05	0.000298	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.61e-05	0.000293	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.57e-05	0.000285	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.55e-05	0.000281	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.54e-05	0.000279	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.46e-05	0.000265	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.41e-05	0.000256	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	1.4e-05	0.000256	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.37e-05	0.00025	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	1.37e-05	0.000249	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.34e-05	0.000243	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	1.29e-05	0.000234	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.27e-05	0.000231	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	0.000228	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.25e-05	0.000228	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.23e-05	0.000224	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.2e-05	0.000219	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.13e-05	0.000206	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	1.13e-05	0.000205	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.08e-05	0.000197	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.02e-05	0.000185	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.96e-06	0.000181	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	9.89e-06	0.00018	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	9.59e-06	0.000175	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	9.34e-06	0.00017	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	8.91e-06	0.000162	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	8.8e-06	0.00016	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.71e-06	0.000158	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	8.57e-06	0.000156	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	8.41e-06	0.000153	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	7.85e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	7.71e-06	0.00014	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.66e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	7.65e-06	0.000139	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.5e-06	0.000136	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.46e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	7.22e-06	0.000131	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	7.16e-06	0.00013	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	7.03e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	6.97e-06	0.000127	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	6.88e-06	0.000125	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.72e-06	0.000122	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.33e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	6.28e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	6.12e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	5.96e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.36e-06	9.76e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.14e-06	9.36e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.72e-06	8.59e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.6e-06	8.37e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.14e-06	7.53e-05	CbGpPWpGaD
